← SynDRA
AKBA
SynDRA canonical compound SYN0007645 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ABCB1 | ALOX5 | HSD11B1 | HSD11B2 |
|---|
| Mechanism of action | lipoxygenase inhibitor |
|---|
All known targets
- HSD11B1
- HSD11B2
- ABCB1
- ALOX5
Mechanisms of action (all sources)
- lipoxygenase inhibitor
- HSD11B2 INHIBITOR
- HSD11B1 INHIBITOR
Cross-references
Synonyms
- 3-acetyl-11-keto-beta-boswellic acid
- 3-O-Acetyl-11-keto-beta-Boswellic Acid
- AKbetaBA
- UNII-BS16QT99Q1
- Acetyl-11-keto-beta-boswellic acid
- CHEMBL237111
- BS16QT99Q1
- Acetyl-11-keto--boswellic acid
- AKBA cpd
- Acetyl-11-keto-b-boswellic acid
- acetyl-11-ketoboswellic acid
- Acetyl-11-keto-beta-Boswellic Acid, Boswellia serrata
- 3-Acetyl-11-keto-
- 3alpha-acetoxy-11-keto-beta-boswellic acid
- Curator_000001
- MolPort-020-005-785
- HMMGKOVEOFBCAU-BCDBGHSCSA-N
- Acetyl-11-Keto-Beta-Boswellic Acid
- 3-O-acetyl-11-keto-boswellic acid
- AcKBA
- RefChem:25878
- DTXCID001733438
- MFCD03788777
- Acetyl-11-keto-|A-boswellic acid
- 3-Acetyl-11-keto-?-boswellic Acid
- AKBA (Standard)
- SCHEMBL23610472
- HY-N0892R
- CHEBI:166842
- HMS6019P06
- Acetyl-11-keto-|?-boswellic acid
- HY-N0892
- 3-Acetyl-11-keto-ss-boswellic acid
- BDBM50241262
- s9024
- AKOS026670207
- CCG-269792
- CS-3736
Look up AKBA in the interactive SynDRA portal →